Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials

Ann Pharmacother. 2024 Nov;58(11):1153-1155. doi: 10.1177/10600280231211304. Epub 2023 Nov 28.

Authors

Marina Sánchez-Rico, Katayoun Rezaei, Eric J Lenze, Frédéric Limosin, Nicolas Hoertel

PMID: 38014845
DOI: 10.1177/10600280231211304

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Drug Treatment*
COVID-19*
Fluvoxamine* / therapeutic use
Humans
Meta-Analysis as Topic
Outpatients
SARS-CoV-2
Selective Serotonin Reuptake Inhibitors / therapeutic use
Treatment Outcome

Substances

Fluvoxamine
Selective Serotonin Reuptake Inhibitors